Case report

Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case report

Sun B, Ding LJ, Wu S, Meng XY, Song S

OncoTargets and Therapy 2016, 9:3997-4003

Published Date: 1 July 2016